Masahiko Shimura, Matthias Bolz,
"Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial"
, in Japan Journal of Ophthalmology, Seite(n) 264-279, 3-2023
Original Titel:
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Forschungs-